Literature DB >> 17180520

Avascular necrosis of bilateral femoral head as a result of long-term steroid administration for radiation pneumonitis after tangential irradiation of the breast.

Yasuhiro Kosaka1, Michihide Mitsumori, Norio Araki, Chikako Yamauchi, Yasushi Nagata, Masahiro Hiraoka, Hiroshi Kodama.   

Abstract

We report a patient with avascular necrosis of the bilateral femoral head resulting from long-term steroid administration for radiation pneumonitis that occurred after tangential irradiation of the breast. The patient was a 50-year-old postmenopausal woman with breast cancer, stage IIIB (T4bN0M0) in the right C area. Following wide excision of right breast carcinoma and level III axillary lymph node dissection, whole-breast X-ray irradiation was given, at a dose of 2 Gy per fraction; the total dose was 50 Gy. On day 84 after the initiation of radiation therapy, she developed radiation pneumonitis. As the lung shadow expanded to the contralateral lung, she received steroid medication. Despite the steroid medication, the symptoms were exacerbated; therefore, she underwent steroid pulse administration with subsequent oral steroid medication. She improved immediately, but subsequently the radiation pneumonitis relapsed three times when the steroid medication was stopped. The period of medication was 423 days and the cumulative amount of steroids was 7365 mg before complete resolution occurred. In the 19 months after she stopped the steroid administration, she developed avascular necrosis (AVN) of the bilateral femoral head. This was regarded as a complication of the steroid treatment. Patients treated with long-term or high-dose steroid administration have been suggested to be at great risk of developing AVN, but this hypothesis remains controversial. The probability of AVN occurrence may be very small, but it should be considered as one of the complications of steroids, which are often used to treat radiation pneumonitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180520     DOI: 10.1007/s10147-006-0607-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  20 in total

1.  Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicity.

Authors:  N Takigawa; Y Segawa; T Saeki; M Kataoka; M Ida; D Kishino; K Fujiwara; S Ohsumi; K Eguchi; S Takashima
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

2.  Radiotherapy-related lung fibrosis enhanced by tamoxifen.

Authors:  S M Bentzen; J Z Skoczylas; M Overgaard; J Overgaard
Journal:  J Natl Cancer Inst       Date:  1996-07-03       Impact factor: 13.506

3.  Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer.

Authors:  Y Segawa; N Takigawa; M Kataoka; I Takata; N Fujimoto; H Ueoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-08-01       Impact factor: 7.038

Review 4.  Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems.

Authors:  S McDonald; P Rubin; T L Phillips; L B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

5.  A newly recognized syndrome--radiation-related bronchiolitis obliterans and organizing pneumonia. A case report and literature review.

Authors:  D E Stover; F Milite; M Zakowski
Journal:  Respiration       Date:  2001       Impact factor: 3.580

6.  Risk factors for avascular bone necrosis in systemic lupus erythematosus.

Authors:  C C Mok; C S Lau; R W Wong
Journal:  Br J Rheumatol       Date:  1998-08

7.  Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model.

Authors:  G Gagliardi; J Bjöhle; I Lax; A Ottolenghi; F Eriksson; A Liedberg; P Lind; L E Rutqvist
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

8.  Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol.

Authors:  C J Glueck; R Freiberg; H I Glueck; T Tracy; D Stroop; Y Wang
Journal:  Am J Hematol       Date:  1995-04       Impact factor: 10.047

9.  Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer.

Authors:  Y Ohe; S Yamamoto; K Suzuki; F Hojo; R Kakinuma; T Matsumoto; H Ohmatsu; Y Nishiwaki
Journal:  Eur J Cancer       Date:  2001-01       Impact factor: 9.162

10.  Hypofibrinolysis: a common, major cause of osteonecrosis.

Authors:  C J Glueck; R Freiberg; H I Glueck; C Henderson; M Welch; T Tracy; D Stroop; T Hamer; F Sosa; M Levy
Journal:  Am J Hematol       Date:  1994-02       Impact factor: 10.047

View more
  4 in total

1.  After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS).

Authors:  Jacqueline P Williams; William H McBride
Journal:  Int J Radiat Biol       Date:  2011-03-21       Impact factor: 2.694

Review 2.  Steroid induced osteonecrosis: An analysis of steroid dosing risk.

Authors:  Christian Powell; Christopher Chang; Stanley M Naguwa; Gurtej Cheema; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2010-07-09       Impact factor: 9.754

Review 3.  Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction?

Authors:  Jacqueline P Williams; Carl J Johnston; Jacob N Finkelstein
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

4.  Therapeutic effect of compound of White Peony Root Oral Liquids on radiation-induced esophageal toxicity via the expression of EGF and TGF-β1.

Authors:  Li Shen; Xing Li; Baoen Shan; Li Zhang; Yanjun Gong; Zhiming Dong; Zhiyu Wang
Journal:  Biomed Rep       Date:  2012-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.